MOMENTUM 3 IDE Clinical Study Protocol

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1028 participants.

Also called NCT02224755

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,028 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02224755
Other papers using this trial's data
  • A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report The New England journal of medicine, 2019-04-25 DOI, PubMed 30883052
  • A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2018-11 DOI, PubMed 30245150
  • Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial JAMA cardiology, 2020-04-01 DOI, PubMed 31939996, PMC6990746 In the PMC Open Access subset under CC BY-NC-ND.
  • Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: An analysis from the MOMENTUM 3 study The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2020-06 DOI, PubMed 32340871, PMC7650304 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study Circulation, 2018-10-30 DOI, PubMed 29807933
  • Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2020-08 DOI, PubMed 32276809

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02224755. Randomized; no masking; primary purpose treatment. Start 2014-09-02 (actual); primary completion 2018-09-28 (actual). Results posted on 2019-11-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MOMENTUM 3 IDE Clinical Study Protocol
Acronym
HM3™
Condition
Advanced Refractory Left Ventricular Heart Failure
Intervention (Device)
HeartMate 3 LVAS
Intervention (Device)
HeartMate II LVAS
Lead sponsor
Abbott Medical Devices (class: industry)
Collaborator
Thoratec Corporation (class: industry)

Record details

Record id
cardio:ct-nct02224755
Content hash
230aea7deb7605dcda816112e0b081acf5617216fc05477d9bcf702ca40d4baf